Publication Name	World Journal of Hepatology
Manuscript ID	23873
Country	Thailand

Received	2015-12-22 09:30
Peer-Review Started	2015-12-22 15:20
First Decision by Editorial Office Director
Return for Revision	2016-01-21 16:05
Revised	2016-02-22 18:26
Publication Fee Transferred
Second Decision by Editor	2016-03-07 15:27
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2016-03-16 16:06
Articles in Press	2016-03-16 16:06
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-21 10:09
Publish the Manuscript Online	2016-03-24 10:34

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Systematic Reviews
Article Title	Comprehensive review of telbivudine in pregnant women with chronic hepatitis B
Manuscript Source	Invited Manuscript
All Author List	Teerha Piratvisuth, Guo Rong Han, Stanislas Pol, Yuhong Dong and Aldo Trylesinski
Funding Agency and Grant Number	Funding Agency Grant Number Novartis Pharma AG
Corresponding Author	Dr. Teerha Piratvisuth, MD, Department of Medicine, NKC Institute of Gastroenterology and Hepatology, Prince of Songkla University, 15 Equipment Acantholysis SOI Road, Hat Yai District, Songkhla 90110, Thailand. teerha.p@psu.ac.th
Key Words	Telbivudine; Hepatitis B virus; Pregnancy; Mother-to-child transmission; Vertical transmission
Core Tip	The data from literatures, pharmacovigilance reports on telbivudine exposure and antiretroviral pregnancy registry during pregnancy in women with hepatitis B virus (HBV) infection showed no increased rates of live birth defects, spontaneous abortion or elective termination. No fetal/neonatal toxicity was reported during telbivudine treatment. Telbivudine exposure in the second and/or third trimesters of pre-gnancy has been shown to reduce the risk of HBV trans-mission from mother to child if administered in addition to hepatitis B immunoglobulin and HBV vaccination with a favorable safety profile.
Publish Date	2016-03-24 10:34
Citation	Piratvisuth T, Han GR, Pol S, Dong Y, Trylesinski A. Compre­hensive review of telbivudine in pregnant women with chronic hepatitis B. World J Hepatol 2016; 8(9): 452-460
URL	http://www.wjgnet.com/1948-5182/full/v8/i9/452.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i9.452

Full Article (PDF)	WJH-8-452.pdf
Full Article (Word)	WJH-8-452.doc
Manuscript File	23873-Review.docx
Answering Reviewers	23873-Answering reviewers.pdf
Audio Core Tip	23873-Audio core tip.MP3
Conflict-of-Interest Disclosure Form	23873-Conflict-of-interest statement.pdf
Copyright License Agreement	23873-Copyright assignment.pdf
Peer-review Report	23873-Peer-review(s).pdf
Scientific Misconduct Check	23873-Scientific misconduct check.pdf
Scientific Editor Work List	23873-Scientific editor work list.pdf